On June 28, 2025, the Founding Assembly of Special Committee on the Prevention and Treatment of Cerebrovascular Diseases of the Hunan Health Management Association, the 3rd Cerebrovascular Disease Forum, the Annual Meeting of the Neurosurgery Professional Committee of Changsha Medical Association, China Geriatric Medicine Society Smart Medical Technology and Management Branch Medical-Engineering Integration Technology Exchange Conference and Annual Meeting of Changsha Science Popularization Education Association Brain Health Popularization Education Professional Committee, were held in Changsha. The conference was hosted by the Hunan Health Management Association, the Smart Medical Technology and Management of the Chinese Geriatrics Society, and the Changsha Medical Association. Nearly 300 experts and clinicians from dozens of hospitals and institutions across the country, including Xiangya Hospital of Central South University, University of Science and Technology of China, People’s Hospital of Wuhan University, and the Third Affiliated Hospital of Wenzhou Medical University, attended the event.
At the launch event, experts and representatives witnessed the official launch of IntelliMicro® Intracranial Pressure Monitoring System, a Class III active implantable medical device developed and manufactured by IntelliMicro Medical Co., Ltd. and approved for registration by the National Medical Products Administration. The product has officially been put into clinical use. It is also the first intracranial pressure monitoring product approved for Class III registration certificate in Hunan.
Class III active implantable medical devices are the top of the pyramid in the field of medical devices, representing the highest regulatory requirements, technical complexity, and R&D difficulty. IntelliMicro® Intracranial Pressure Monitoring System is composed of two parts: intracranial pressure monitor and intracranial pressure sensor kit, both of which are Class III medical devices, and will provide strong scientific and technological support for the protection of the most sophisticated “vital center” of human beings.
Focus on Clinical Demands: Accurate Monitoring to Protect Key Indicators of Life
Accurate, real-time, and dynamic monitoring of intracranial pressure and temperature is the key process in the field of neurosurgery and intensive care medicine for assessing the conditions, guiding treatment, and saving lives.
After several years of research and development, the IntelliMicro® Intracranial Pressure Monitoring System has successfully overcome technical difficulties. It can accurately capture the continuous and dynamic changes of intracranial pressure and temperature of patients through a miniaturized, highly sensitive implantable sensor kit, and at the same time, it combines with the real-time display of intelligent intracranial pressure monitor to provide doctors with critical and reliable real-time data. The core advantage of this product is that it can significantly help doctors to more accurately assess the condition and formulate and optimize individualized treatment plans, so as to effectively improve the success rate of treatment of patients with severe neurological diseases and build a solid technological defense line for patients with a variety of craniocerebral diseases.
In process of product research and development, IntelliMicro has also carried out in-depth cooperation with the clinical expert teams of Xiangya Hospital of Central South University and Hunan Brain Hospital, starting from the demands of clinical problems, continuously optimizing the clinical path, core index setting and early warning logic of the product. The animal experiment data shows that the technical indicators and effectiveness of the product have reached the technical parameters of similar foreign advanced products, and the clinical applicability and authority of the product have been effectively guaranteed.
Gathering of Experts: A New Era of Precise Intracranial Health Management
This launch event brought together top experts and scholars, and core partners in the fields of neurosurgery and intensive care medicine in China to look forward to the future of precision intracranial health management.
In the eager anticipation of the guests, Dr. Tian Hongjun, Vice President and Technical Lead of IntelliMicro, took the stage and gave a comprehensive and in-depth introduction to the innovative technology, core performance indicators and convenient operation process of the IntelliMicro® Intracranial Pressure Monitoring System.
Set Sail: Strategic Signing to Accelerate Product Inclusion and Protect Life and Health
The exciting launch ceremony of the product launch brought the atmosphere to a climax. Representatives of clinicians and experts and IntelliMicro jointly launched the holographic start-up device which symbolizing the power of science and technology and the hope of life, and the IntelliMicro® Intracranial Pressure Monitoring System was officially launched.
A grand strategic signing ceremony was held at the end of the launch event, IntelliMicro signed cooperation agreements with a number of core regional strategic partners such as Sinopharm Group Changsha Co., Ltd., Hunan Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical Commercial Group Co., Ltd., Sinopharm Group Jiangxi Medical Device Supply Chain Co., Ltd., Hubei Deshang Industry and Trade Co., Ltd., and Changsha New Progress Medical Device Co., Ltd. This signifies that the IntelliMicro® Intracranial Pressure Monitoring System will accelerate the coverage of medical institutions at all levels by relying on the strong and efficient channel network and a professional and timely service system, ensuring that the innovative achievements can rapidly and extensively benefit patients in urgent need.
IntelliMicro has always believed that the ultimate goal of technological innovation is to transform technology into an inclusive force to protect human life and health. In the future, IntelliMicro will continue to increase its R&D investment, deepen its cooperation with medical institutions, and strive to launch more affordable innovative medical device products with high clinical value and great reliability, and contribute to improving the health level and well-being of all mankind through continuous scientific and technological innovation.